GLSI
Price
$10.03
Change
+$0.15 (+1.52%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
134.08M
39 days until earnings call
OBIO
Price
$2.89
Change
+$0.01 (+0.35%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
110.34M
Interact to see
Advertisement

GLSI vs OBIO

Header iconGLSI vs OBIO Comparison
Open Charts GLSI vs OBIOBanner chart's image
Greenwich LifeSciences
Price$10.03
Change+$0.15 (+1.52%)
Volume$679
Capitalization134.08M
Orchestra BioMed Holdings
Price$2.89
Change+$0.01 (+0.35%)
Volume$7.14K
Capitalization110.34M
GLSI vs OBIO Comparison Chart in %
Loading...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLSI vs. OBIO commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLSI is a Hold and OBIO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (GLSI: $10.03 vs. OBIO: $2.89)
Brand notoriety: GLSI and OBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLSI: 84% vs. OBIO: 28%
Market capitalization -- GLSI: $134.08M vs. OBIO: $110.34M
GLSI [@Biotechnology] is valued at $134.08M. OBIO’s [@Biotechnology] market capitalization is $110.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLSI’s FA Score shows that 0 FA rating(s) are green whileOBIO’s FA Score has 0 green FA rating(s).

  • GLSI’s FA Score: 0 green, 5 red.
  • OBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, OBIO is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLSI’s TA Score shows that 6 TA indicator(s) are bullish while OBIO’s TA Score has 5 bullish TA indicator(s).

  • GLSI’s TA Score: 6 bullish, 4 bearish.
  • OBIO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GLSI is a better buy in the short-term than OBIO.

Price Growth

GLSI (@Biotechnology) experienced а +12.32% price change this week, while OBIO (@Biotechnology) price change was -3.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

GLSI is expected to report earnings on Aug 11, 2025.

OBIO is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLSI($134M) has a higher market cap than OBIO($110M). GLSI YTD gains are higher at: -10.686 vs. OBIO (-27.750). GLSI has higher annual earnings (EBITDA): -16.75M vs. OBIO (-68.48M). OBIO has more cash in the bank: 49.9M vs. GLSI (2.75M). OBIO has higher revenues than GLSI: OBIO (2.89M) vs GLSI (0).
GLSIOBIOGLSI / OBIO
Capitalization134M110M122%
EBITDA-16.75M-68.48M24%
Gain YTD-10.686-27.75039%
P/E RatioN/AN/A-
Revenue02.89M-
Total Cash2.75M49.9M6%
Total DebtN/A16.4M-
TECHNICAL ANALYSIS
Technical Analysis
GLSIOBIO
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
55%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
50%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
50%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 2 days ago
60%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 4 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
61%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AFGVY1.33N/A
N/A
Agfa-Gavaert NV
BTLLF0.55N/A
N/A
North Peak Resources Ltd.
KURRY35.65N/A
N/A
Kuraray Co.
YZCAY10.38-0.03
-0.24%
YANKUANG ENERGY GROUP CO LTD.
STHRF22.19-0.36
-1.58%
STRATHCONA RES LTD.

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ABOS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
+1.52%
ABOS - GLSI
48%
Loosely correlated
+2.65%
DNLI - GLSI
46%
Loosely correlated
-1.41%
CLDX - GLSI
46%
Loosely correlated
-0.50%
BEAM - GLSI
45%
Loosely correlated
+0.65%
CRSP - GLSI
44%
Loosely correlated
+0.97%
More

OBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, OBIO has been loosely correlated with XERS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if OBIO jumps, then XERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OBIO
1D Price
Change %
OBIO100%
+0.35%
XERS - OBIO
39%
Loosely correlated
+0.42%
GBIO - OBIO
39%
Loosely correlated
+1.51%
ABEO - OBIO
38%
Loosely correlated
+0.34%
OCUL - OBIO
38%
Loosely correlated
+1.69%
GLSI - OBIO
38%
Loosely correlated
+1.52%
More